Owens & Minor (NYSE:OMI – Free Report) had its target price reduced by Robert W. Baird from $15.00 to $14.00 in a report issued on Tuesday morning,Benzinga reports. They currently have a neutral rating on the stock.
OMI has been the topic of several other reports. Barclays cut their price objective on shares of Owens & Minor from $18.00 to $14.00 and set an “equal weight” rating on the stock in a report on Tuesday, November 5th. Citigroup cut their price objective on shares of Owens & Minor from $21.00 to $18.50 and set a “buy” rating on the stock in a report on Tuesday, November 5th. Finally, UBS Group cut their price objective on shares of Owens & Minor from $28.00 to $25.00 and set a “buy” rating on the stock in a report on Tuesday, November 5th. Two equities research analysts have rated the stock with a sell rating, five have assigned a hold rating and two have given a buy rating to the company. According to data from MarketBeat, the company presently has an average rating of “Hold” and an average price target of $18.50.
Check Out Our Latest Report on Owens & Minor
Owens & Minor Stock Performance
Owens & Minor (NYSE:OMI – Get Free Report) last issued its quarterly earnings data on Monday, November 4th. The company reported $0.42 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.41 by $0.01. The company had revenue of $2.72 billion for the quarter, compared to analyst estimates of $2.68 billion. Owens & Minor had a negative net margin of 0.46% and a positive return on equity of 14.60%. Owens & Minor’s revenue was up 5.0% compared to the same quarter last year. During the same period last year, the company posted $0.44 earnings per share. As a group, equities analysts forecast that Owens & Minor will post 1.49 earnings per share for the current year.
Insiders Place Their Bets
In other news, CFO Jonathan A. Leon sold 5,282 shares of the business’s stock in a transaction on Thursday, November 21st. The shares were sold at an average price of $11.82, for a total transaction of $62,433.24. Following the sale, the chief financial officer now directly owns 130,822 shares of the company’s stock, valued at $1,546,316.04. The trade was a 3.88 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Corporate insiders own 2.62% of the company’s stock.
Institutional Investors Weigh In On Owens & Minor
A number of large investors have recently made changes to their positions in OMI. Quarry LP lifted its position in Owens & Minor by 290.1% during the second quarter. Quarry LP now owns 2,099 shares of the company’s stock valued at $28,000 after purchasing an additional 1,561 shares during the period. Blue Trust Inc. lifted its position in Owens & Minor by 57.4% during the fourth quarter. Blue Trust Inc. now owns 4,387 shares of the company’s stock valued at $57,000 after purchasing an additional 1,600 shares during the period. The Manufacturers Life Insurance Company lifted its position in Owens & Minor by 4.9% during the second quarter. The Manufacturers Life Insurance Company now owns 36,366 shares of the company’s stock valued at $491,000 after purchasing an additional 1,709 shares during the period. KBC Group NV boosted its stake in shares of Owens & Minor by 98.2% during the 4th quarter. KBC Group NV now owns 4,434 shares of the company’s stock worth $58,000 after acquiring an additional 2,197 shares in the last quarter. Finally, Segall Bryant & Hamill LLC boosted its stake in shares of Owens & Minor by 2.1% during the 3rd quarter. Segall Bryant & Hamill LLC now owns 137,199 shares of the company’s stock worth $2,153,000 after acquiring an additional 2,883 shares in the last quarter. 98.04% of the stock is owned by hedge funds and other institutional investors.
Owens & Minor Company Profile
Owens & Minor, Inc, together with its subsidiaries, operates as a healthcare solutions company worldwide. It operates through Products & Healthcare Services and Patient Direct segments. The Products & Healthcare Services segment offers a portfolio of products and services to healthcare providers and manufacturers.
Recommended Stories
- Five stocks we like better than Owens & Minor
- Stock Ratings and Recommendations: Understanding Analyst Ratings
- Price Plunge in Roblox Presents Opportunity for Robust Gains
- Investing In Automotive Stocks
- Billions in Buybacks: 4 Stocks Rewarding Shareholders Now
- What Are Dividend Challengers?
- 3 Steel Stocks to Gain Strength as Tariffs Reshape the Market
Receive News & Ratings for Owens & Minor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Owens & Minor and related companies with MarketBeat.com's FREE daily email newsletter.